Navigation Links
Preteens More Likely to Report HPV Vaccine Side Effects
Date:4/3/2012

TUESDAY, April 3 (HealthDay News) -- A new study finds that preteen girls are more likely than older teens and adult women to experience side effects after receiving the human papillomavirus (HPV) vaccine, Gardasil.

However, the side effects are not serious and are similar to those associated with other vaccines.

U.S. researchers surveyed about 900 girls and young women, aged 11 to 26, within two weeks after they received the Gardasil vaccine injection in the upper arm. The vaccine protects against HPV infection, which is sexually transmitted and a cause of cervical cancer.

Seventy-eight percent of the patients reported pain when receiving the vaccine; 17 percent reported bruising or discoloration; 14 percent reported swelling at the injection site; 15 percent reported dizziness, and 1 percent of the girls fainted.

Younger patients were more likely to have received other vaccines -- such as tetanus, meningitis, and hepatitis A -- at the same time they received the HPV vaccine, and were also more likely to report side effects, the study found.

For example, pain during the injection was reported by 84 percent of girls aged 11 to 12 versus 74 percent of women aged 18 to 26. Dizziness after receiving the vaccine was reported by 19 percent of girls aged 11 to 12 compared to 8 percent of women ages 18 to 26.

The U.S. Centers for Disease Control and Prevention-funded study was published April 3 in the Journal of Women's Health.

"Gardasil is an important cancer prevention vaccine, but too few girls are getting it," lead author Allison Naleway, a senior investigator with the Kaiser Permanente Center for Health Research in Portland, Ore., said in a Kaiser news release. "Our study found that young girls do have some knowledge about the vaccine, but they need to know more. If these girls and their parents know what to expect, they will likely be less afraid of getting the vaccine."

Dr. Mike Wilmington, a Kaiser Permanente pediatrician in Vancouver, Wash., who was not involved in the study, said the side effects are non-serious and very manageable.

"The main complaint I hear about is pain with the injection, but there are ways to lessen the pain," he said in the news release."Some girls will feel dizzy after this and other vaccines, so I follow CDC guidelines and have them sit or lie down for a few minutes after receiving the vaccine."

The CDC recommends the three-dose Gardasil vaccination for girls aged 11 to 12, for older girls and women (aged 13 to 26) who did not receive the vaccine when they were younger, for boys aged 11 to 12, and for older boys and men (aged 13 to 21) who did not receive the vaccine when they were younger.

Most of the girls and young women surveyed knew that the vaccine can prevent cervical cancer and that three doses are suggested, but many were unaware that Gardasil can also prevent genital warts and abnormal Pap smears, the researchers said.

More information

The U.S. National Cancer Institute has more about HPV vaccines.

-- Robert Preidt

SOURCE: Kaiser Permanente, news release, April 3, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Preteens surrounded by smokers get hooked on nicotine
2. Preteens With Conduct Disorders Risk Violence, Delinquency as Teens
3. Young girls more likely to report side effects after HPV vaccine
4. Changes in Insurance Make ER Visits More Likely: Study
5. Doctors Likely to Preach What They Practice
6. African-Americans 7 times more likely to have keloid scarring of the head, neck
7. School bullies more likely to be substance users, study finds
8. Study: Over 100,000 Californians likely to miss out on health care due to language barriers
9. Poor Patients Less Likely to Sue Doctors, Analysis Shows
10. Younger patients more likely to live a decade or longer after heart transplant
11. The poor, in fact, are less likely to sue their doctor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Preteens More Likely to Report HPV Vaccine Side Effects
(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: